Skip to main content

Ajanta Pharma USA Inc

Recalls

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20262
Download CSV

FDA Recall Ongoing 2026 recordClass II

Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.

by Ajanta Pharma USA Inc

Reason
CGMP Deviations
Published
July 1, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.

by Ajanta Pharma USA Inc

Reason
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
Published
June 24, 2026
Distribution
Nationwide

View recall →

Showing 1–2 of 2 results

This page lists recalls that name Ajanta Pharma USA Inc as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.